Development of Hong Kong liver cancer staging system with treatment stratification for patients with hepatocellular carcinoma

Gastroenterology

Volumn 146, Issue 7, 2014, Pages

  Yau, Thomas ^a   Tang, Vikki Y F ^a,b   Yao, Tzy Jyun ^b   Fan, Sheung Tat ^a   Lo, Chung Mau ^a   Poon, Ronnie T P ^a  

^a THE UNIVERSITY OF HONG KONG   (Hong Kong)

^b UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

Outcome; Overall Survival; Prediction Model; TACE

Indexed keywords

ADULT; AGED; ARTICLE; CANCER SIZE; CANCER STAGING; CANCER SURVIVAL; CHEMOEMBOLIZATION; CHILD PUGH SCORE; FEMALE; HEPATITIS B; HONG KONG; HUMAN; LIVER CELL CARCINOMA; MAJOR CLINICAL STUDY; MALE; METASTASIS; OVERALL SURVIVAL; PRIORITY JOURNAL; PROPORTIONAL HAZARDS MODEL; RECEIVER OPERATING CHARACTERISTIC; SURVIVAL RATE; SURVIVAL TIME; SYSTEMIC THERAPY; TUMOR INVASION;

OUTCOME; OVERALL SURVIVAL; PREDICTION MODEL; TACE;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; AREA UNDER CURVE; ASIAN CONTINENTAL ANCESTRY GROUP; CARCINOMA, HEPATOCELLULAR; CHI-SQUARE DISTRIBUTION; DECISION SUPPORT TECHNIQUES; DECISION TREES; FEMALE; HONG KONG; HUMANS; KAPLAN-MEIER ESTIMATE; LIVER NEOPLASMS; MALE; MIDDLE AGED; NEOPLASM STAGING; PATIENT SELECTION; PREDICTIVE VALUE OF TESTS; PROPORTIONAL HAZARDS MODELS; RETROSPECTIVE STUDIES; RISK ASSESSMENT; RISK FACTORS; ROC CURVE; TIME FACTORS; TREATMENT OUTCOME; YOUNG ADULT;

EID: 84901258639     PISSN: 00165085     EISSN: 15280012     Source Type: Journal    
DOI: 10.1053/j.gastro.2014.02.032     Document Type: Article

References (46)

1. J. Ferlay, H.R. Shin, and F. Bray et al. GLOBOCAN 2008 v1.2, cancer incidence and mortality worldwide: IARC cancerbase no. 10. Volume 2011 2010 International Agency for Research on Cancer Lyon, France
2. G. Fattovich, T. Stroffolini, and I. Zagni et al. Hepatocellular carcinoma in cirrhosis: incidence and risk factors Gastroenterology 127 2004 S35 S50
3. H.B. El-Serag, and K.L. Rudolph Hepatocellular carcinoma: epidemiology and molecular carcinogenesis Gastroenterology 132 2007 2557 2576
4. S. Caldwell, and S.H. Park The epidemiology of hepatocellular cancer: from the perspectives of public health problem to tumor biology J Gastroenterol 44 Suppl XIX 2009 96 101
5. S.C. Lu Where are we in the chemoprevention of hepatocellular carcinoma? Hepatology 51 2010 734 736
6. J.M. Henderson, M. Sherman, and A. Tavill et al. AHPBA/AJCC consensus conference on staging of hepatocellular carcinoma: consensus statement HPB (Oxford) 5 2003 243 250
7. K. Okuda, T. Ohtsuki, and H. Obata et al. Natural history of hepatocellular carcinoma and prognosis in relation to treatment. Study of 850 patients Cancer 56 1985 918 928
8. The Cancer of the Liver Italian Program (CLIP) Investigators A new prognostic system for hepatocellular carcinoma: a retrospective study of 435 patients Hepatology 28 1998 751 755
9. S. Chevret, J.C. Trinchet, and D. Mathieu et al. A new prognostic classification for predicting survival in patients with hepatocellular carcinoma J Hepatol 31 1999 133 141
10. J.M. Llovet, C. Bru, and J. Bruix Prognosis of hepatocellular carcinoma: the BCLC staging classification Semin Liver Dis 19 1999 329 338
11. T.W. Leung, A.M. Tang, and B. Zee et al. Construction of the Chinese University Prognostic Index for hepatocellular carcinoma and comparison with the TNM staging system, the Okuda staging system, and the Cancer of the Liver Italian Program staging system: a study based on 926 patients Cancer 94 2002 1760 1769
12. M. Kudo, H. Chung, and Y. Osaki Prognostic staging system for hepatocellular carcinoma (CLIP score): its value and limitations, and a proposal for a new staging system, the Japan Integrated Staging Score (JIS score) J Gastroenterol 38 2003 207 215
13. J. Bruix, and J.M. Llovet Prognostic prediction and treatment strategy in hepatocellular carcinoma Hepatology 35 2002 519 524
14. J.M. Llovet, A. Burroughs, and J. Bruix Hepatocellular carcinoma Lancet 362 2003 1907 1917
15. J.M. Llovet, A.M. Di Bisceglie, and J. Bruix et al. Design and endpoints of clinical trials in hepatocellular carcinoma J Natl Cancer Inst 100 2008 698 711
16. A. Forner, M.E. Reig, and C.R. de Lope et al. Current strategy for staging and treatment: the BCLC update and future prospects Semin Liver Dis 30 2010 61 74
17. J. Bruix, M. Sherman, and J.M. Llovet et al. Clinical management of hepatocellular carcinoma. Conclusions of the Barcelona-2000 EASL conference J Hepatol 35 2001 421 430
18. J. Bruix, and M. Sherman Management of hepatocellular carcinoma Hepatology 42 2005 1208 1236
19. M. Kudo, K.H. Han, and N. Kokudo et al. Liver cancer working group report Jpn J Clin Oncol 40 Suppl 1 2010 i19 i27
20. S.L. Chan, F.K.F. Mo, and P.J. Johnson et al. Prospective validation of the Chinese University Prognostic Index and comparison with other staging systems for hepatocellular carcinoma in an Asian population J Gastroenterol Hepatol 26 2011 340 347
21. M. Kudo, N. Izumi, and N. Kokudo et al. Management of hepatocellular carcinoma in Japan: Consensus-Based Clinical Practice Guidelines proposed by the Japan Society of Hepatology (JSH) 2010 updated version Dig Dis 29 2011 339 364
22. M. Omata, L.A. Lesmana, and R. Tateishi et al. Asian Pacific Association for the Study of the Liver consensus recommendations on hepatocellular carcinoma Hepatol Int 4 2010 439 474
23. Korean Liver Cancer Study Group and National Cancer Center Korea. Practice guidelines for management of hepatocellular carcinoma 2009 Korean J Hepatol 15 2009 391 423
24. V. Mazzaferro, E. Regalia, and R. Doci et al. Liver transplantation for the treatment of small hepatocellular carcinomas in patients with cirrhosis N Engl J Med 334 1996 693 699
25. F.Y. Yao, L. Ferrell, and N.M. Bass et al. Liver transplantation for hepatocellular carcinoma: expansion of the tumor size limits does not adversely impact survival Hepatology 33 2001 1394 1403
26. R Development Core Team R: a language and environment for statistical computing 2009 R Foundation for Statistical Computing Vienna, Austria
27. S. van Buuren, H.C. Boshuizen, and D.L. Knook Multiple imputation of missing blood pressure covariates in survival analysis Stat Med 18 1999 681 694
28. D.B. Rubin Multiple imputation for nonresponse in surveys 1987 John Wiley & Sons
29. D.R. Cox Regression models and life tables J R Stat Soc B34 1972 187 220
30. L. Breiman, J.H. Friedman, and R.A. Olshen et al. Classification and regression trees 1984 Chapman & Hall/CRC
31. T.M. Therneau, and P.M. Grambsch Modeling survival data: extending the Cox model 2000 Springer-Verlag
32. L.M. Sullivan, J.M. Massaro, and R.B. D'Agostino Sr. Presentation of multivariate data for clinical use: the Framingham Study risk score functions Stat Med 23 2004 1631 1660
33. C.B. Begg, L.D. Cramer, and E.S. Venkatraman et al. Comparing tumour staging and grading systems: a case study and a review of the issues, using thymoma as a model Stat Med 19 2000 1997 2014
34. U. Cillo, M. Bassanello, and A. Vitale et al. The critical issue of hepatocellular carcinoma prognostic classification: which is the best tool available? J Hepatol 40 2004 124 131
35. E. Giannini, D. Risso, and F. Botta et al. Prognosis of hepatocellular carcinoma in anti-HCV positive cirrhotic patients: a single-centre comparison amongst four different staging systems J Intern Med 255 2004 399 408
36. A. Grieco, M. Pompili, and G. Caminiti et al. Prognostic factors for survival in patients with early-intermediate hepatocellular carcinoma undergoing nonsurgical therapy: comparison of Okuda, CLIP, and BCLC staging systems in a single Italian centre Gut 54 2005 411 418
37. J.A. Marrero, R.J. Fontana, and A. Barrat et al. Prognosis of hepatocellular carcinoma: comparison of 7 staging systems in an American cohort Hepatology 41 2005 707 716
38. U. Cillo, A. Vitale, and F. Grigoletto et al. Prospective validation of the Barcelona Clinic Liver Cancer staging system J Hepatol 44 2006 723 731
39. T.W. Chen, C.M. Chu, and J.C. Yu et al. Comparison of clinical staging systems in predicting survival of hepatocellular carcinoma patients receiving major or minor hepatectomy Eur J Surg Oncol 33 2007 480 487
40. Y.K. Cho, J.W. Chung, and J.K. Kim et al. Comparison of 7 staging systems for patients with hepatocellular carcinoma undergoing transarterial chemoembolization Cancer 112 2008 352 361
41. J.H. Wang, C.S. Changchien, and T.H. Hu et al. The efficacy of treatment schedules according to Barcelona Clinic Liver Cancer staging for hepatocellular carcinoma - survival analysis of 3892 patients Eur J Cancer 44 2008 1000 1006
42. A. Vitale, E. Saracino, and P. Boccagni et al. Validation of the BCLC prognostic system in surgical hepatocellular cancer patients Transplant Proc 41 2009 1260 1263
43. T. Ishizawa, K. Hasegawa, and T. Aoki et al. Neither multiple tumors nor portal hypertension are surgical contraindications for hepatocellular carcinoma Gastroenterology 134 2008 1908 1916
44. M.C. Ho, G.T. Huang, and Y.M. Tsang et al. Liver resection improves the survival of patients with multiple hepatocellular carcinomas Ann Surg Oncol 16 2009 848 855
45. I. Ikai, Y. Yamamoto, and N. Yamamoto et al. Results of hepatic resection for hepatocellular carcinoma invading major portal and/or hepatic veins Surg Oncol Clin North Am 12 2003 65 75
46. T.M. Pawlik, R.T. Poon, and E.K. Abdalla et al. Hepatectomy for hepatocellular carcinoma with major portal or hepatic vein invasion: results of a multicenter study Surgery 137 2005 403 410